MENU

MDRX Stock Veradigm (MDRX, $5.46) RSI Indicator left the oversold zone on January 31, 2025

A.I.dvisor
at Tickeron.com
Loading...
MDRX - Veradigm Inc.
RSI signal
Bullish Trend
Odds of UP Trend
Tickeron
RSI signal
Price: $5.46
Daily change: -$2.55 (-31.81%)
Daily volume: 13M
Capitalization: $587.2M
Industry: Packaged Software
This is a signal that MDRX's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options. A.I.dvisor looked back and found 41 similar cases where MDRX's RSI Indicator left the oversold zone, and in of them led to a successful outcome. Odds of Success:

MDRX in upward trend: price expected to rise as it breaks its lower Bollinger Band on January 31, 2025

MDRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 54 cases where MDRX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MDRX's RSI Oscillator exited the oversold zone, of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on February 18, 2025. You may want to consider a long position or call options on MDRX as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MDRX just turned positive on February 18, 2025. Looking at past instances where MDRX's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDRX advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for MDRX moved below the 200-day moving average on February 06, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MDRX entered a downward trend on February 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.632) is normal, around the industry mean (30.944). P/E Ratio (7.919) is within average values for comparable stocks, (160.639). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (2.763). Dividend Yield (0.000) settles around the average of (0.086) among similar stocks. P/S Ratio (0.487) is also within normal values, averaging (58.213).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MDRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

View a ticker or compare two or three
MDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of information technology solutions and services to healthcare organizations

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
Information Technology Services
Address
222 Merchandise Mart Plaza
Phone
+1 800 334-8534
Employees
8000
Web
https://www.veradigm.com